
Takeda’s Orzeyful, the first orexin agonist for narcolepsy type 1, is now available in the U.S. at a whole acquisition list price of $16,500 per 60-tablet bottle.
New Formulations/Combinations: Pediatric-specific albuterol formulation; fixed-dose bronchodilator combination






